Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study

Table 4

Adverse drug reactions attributed to intravenous mistletoe therapy.

System Organ Class	Preferred term	Total patients	Total events	Incidence (%)
Gastrointestinal disorders	Hypoaesthesia oral	1	1	0.2
	Vomiting	1	1	0.2
Gastrointestinal disorders total		2	2	0.2
General disorders and administration site conditions	Pyrexia	8	10	1.7
	Chills	1	1	0.2
	Fatigue	1	1	0.2
	Infusion site inflammation	1	1	0.2
	Local reaction	2	2	0.4
General disorders and administration site conditions total		10	15	2.1
Immune system disorders	Hypersensitivity	1	2	0.2
Immune system disorders total		1	2	0.2
Musculoskeletal and connective tissue disorders	Myalgia	1	1	0.2
Musculoskeletal and connective tissue disorders total		1	1	0.2
Nervous system disorders	Headache	1	1	0.2
	Paraesthesia	1	1	0.2
Nervous system disorders total		2	2	0.2
Skin and subcutaneous tissue disorders	Pruritus	6	6	1.3
	Rash	1	1	0.2
	Urticaria	3	3	0.6
Skin and subcutaneous tissue disorders total		10	10	2.1
Total		22	32	4.6